Skip to content
Screener

Ovintiv OVV EPS (Diluted)

EPS (Diluted) at other companies

Veradermics logo
VeradermicsMANE
-$1.32+93.3%
BK
BKBK
$2.24+41.8%
Polaryx Therapeutics, Inc. logo
Polaryx Therapeutics, Inc.PLYX
-$0.05+54.5%
Schering-Plough logo
Schering-PloughSGP
-$0.69+82.6%
Barnes Group logo
Barnes GroupB
-$0.04+90.7%
Xcel Energy logo
Xcel EnergyXEL
$0.89+6.0%

Other financials

Income statement

See full
Revenue$3.0B+30.0%
Operating income$994.0M+94.5%
Net income$456.0M+48.5%

Balance sheet

See full
Cash & equivalents$700.0M+3,400%
Total debt$5.0B-23.8%
Total equity$11.5B+10.8%
Total assets$19.3B-2.3%

Cash flow

See full
Operating cash flow$1.6B+61.1%
CapEx$574.0M+10.2%
Free cash flow$1.1B+115%

Valuation

See full
Market cap$17.36B+61.0%
Enterprise value$21.69B+24.9%
P/E18.9×+2.4×
P/S1.8×+0.6×

Profitability

See full
Operating margin9.7%-0.6pp
Net margin9.4%+2.3pp
FCF margin23.2%+4.8pp

Returns & leverage

See full
Return on equity8.4%+2.1pp
Debt / equity0.4×-0.2×
Current ratio+0.6×

Where this comes from

Reported directly by Ovintiv in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Ovintiv’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-314501
(US$ millions, except per share amounts) / RevenuesThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Income tax expense (recovery)8392(114)58
Net Earnings (Loss)$456$307$(174)$148
Net Earnings (Loss) per Share of Common Stock
Basic$1.63$1.19$(0.63)$0.57
Diluted1.621.18(0.63)0.57
Weighted Average Shares of Common Stock Outstanding (millions)
Basic280.0259.0274.1259.7
Diluted281.9260.1274.1261.6

Item 1. Financial Statements

FAQ

What is Ovintiv's EPS (diluted)?
Ovintiv (OVV) reported EPS (diluted) of $1.62 in Q2 2026.
How has Ovintiv's EPS (diluted) changed year-over-year?
Ovintiv's EPS (diluted) increased by 37.3% year-over-year, from $1.18 to $1.62.
What is the long-term trend for Ovintiv's EPS (diluted)?
Over 4 years (2021 to 2025), Ovintiv's EPS (diluted) has grown at a -2.5% compound annual growth rate (CAGR), from $5.29 to $4.79.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Ovintiv's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude